Detalles de la búsqueda
1.
Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial.
Jpn J Clin Oncol
; 53(1): 4-15, 2023 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36398439
2.
Inhibition of macrophage activation and suppression of graft rejection by DTCM-glutarimide, a novel piperidine derived from the antibiotic 9-methylstreptimidone.
Inflamm Res
; 60(9): 879-88, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21625968
3.
The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.
Am J Cancer Res
; 10(12): 4399-4415, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33415007
4.
Inhibition of RANKL- and LPS-induced osteoclast differentiations by novel NF-κB inhibitor DTCM-glutarimide.
Int Immunopharmacol
; 25(1): 162-8, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25617668
Resultados
1 -
4
de 4
1
Próxima >
>>